About Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie
During the past decade, Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract
2016-11-30
2022-12-12
Completed
1,005
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen
2017-01-10
2022-12-20
Completed
772
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie
According to Clinical.Site data, the most researched conditions in "Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie" are
"Prostatic Neoplasms, Castration-Resistant" (1 trials) and "Urinary Tract Cancer" (1 trials). Many other conditions were trialed in "Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie" in a lesser frequency.
Clinical Trials Intervention Types at Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie
Most popular intervention types in "Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials) and "Enzalutamide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie
The vast majority of trials in "Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie" are
1 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie
Currently, there are NaN active trials in "Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".